Internal Medicine, Medical Oncology · Aurora, CO
NPI
1568552230
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
12605 E 16th Ave
Aurora, CO, 80045
Phone (720) 848-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
458 services
Medicare patients, 2024
210
Average age 75
Drug cost, 2024
$5.0M
515 prescriptions
Company payments, 2025
$16.7
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William Robinson was code 99214 (office e&m - established), 271 times for 145 patients. In total William Robinson billed 458 services in 17 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 271 | 145 | $68.39 | $19K |
| 99213 Office E&M - Established | Facility | 129 | 97 | $41.76 | $5,388 |
By year: 2022 $28K for 477 services; 2023 $33K for 551 services; 2024 $27K for 458 services.
Medicare prescription drug claims, 2024
In 2024, the drug William Robinson prescribed most often to Medicare patients was Calquence (Acalabrutinib Maleate), with 75 prescriptions and refills. In total William Robinson wrote 515 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calquence Acalabrutinib Maleate | 75 | 75 | Under 11 | $685K |
| Ayvakit Avapritinib | 75 | 75 | Under 11 | $3.2M |
| Imatinib Mesylate Generic | 46 | 46 | Under 11 | $4,073 |
| Imbruvica Ibrutinib | 29 | 37 | Under 11 | $342K |
| Brukinsa Zanubrutinib | 24 | 24 | Under 11 | $175K |
| Venclexta Venetoclax | 22 | 22 | Under 11 | $143K |
| Allopurinol Generic | 22 | 40 | Under 11 | $144 |
| Acyclovir Generic | 19 | 41 | Under 11 | $542 |
| Prednisone Generic | 19 | 30 | Under 11 | $123 |
| Triamcinolone Acetonide Generic | 16 | 16 | Under 11 | $96.33 |
| Ibrance Palbociclib | 13 | 13 | Under 11 | $191K |
| Braftovi Encorafenib | 12 | 12 | Under 11 | $91K |
| Mektovi Binimetinib | 11 | 11 | Under 11 | $79K |
Brand drugs: 280 claims; generic drugs: 235 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William Robinson $16.7 ($16.7 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $16.7.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $16.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.